Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Single and Multiple Dose Study Evaluating the Safety and Tolerability of RPh201 in Healthy Subjects and in Adults With Alzheimer's Disease

NCT01513967 is registered in ClinicalTrials.gov with Regenera Pharma Ltd as lead sponsor.

NCT NCT01513967
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01513967 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Single and Multiple Dose Study Evaluating the Safety and Tolerability of RPh201 in Healthy Subjects and in Adults With Alzheimer's Disease
Lead sponsor
Regenera Pharma Ltd
Phase
Phase 1/2
Overall status
Completed
Start date
January 31, 2012
Completion date
June 30, 2015
Enrollment
39 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers, moderate to severe alzheimer patients